Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Zhavoronkov

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Nature Medicine|February 7, 2023
Caution with AI-generated content in biomedicineAlex Zhavoronkov
Journal of Chemical Information and Modeling|May 30, 2020
Medicinal Chemists versus Machines Challenge: What Will It Take to Adopt and Advance Artificial Intelligence for Drug Discovery?Alex Zhavoronkov
Oncoscience|January 2, 2023
Rapamycin in the context of Pascal's Wager: generative pre-trained transformer perspective, Alex Zhavoronkov
Science (New York, N.Y.)|May 9, 2020
The inherent challenges of classifying senescenceAlex Zhavoronkov
Aging|April 2, 2020
Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infectionsAlex Zhavoronkov
Psychology Research and Behavior Management|February 6, 2015
Longevity expectations in the pension fund, insurance, and employee benefits industriesAlex Zhavoronkov
Molecular Pharmaceutics|October 2, 2018
Artificial Intelligence for Drug Discovery, Biomarker Development, and Generation of Novel ChemistryAlex Zhavoronkov
Trends in Molecular Medicine|August 11, 2019
The Advent of Human Life Data Economics: (Trends in Molecular Medicine 25, 566-570; 2019)Alex Zhavoronkov, George Church
International Journal of Environmental Research and Public Health|November 13, 2013
Biomedical progress rates as new parameters for models of economic growth in developed countriesAlex Zhavoronkov, Maria Litovchenko
Clinical Pharmacology and Therapeutics|December 26, 2024
Progress, Pitfalls, and Impact of AI-Driven Clinical TrialsDominika Wilczok, Alex Zhavoronkov
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Nature Medicine|February 7, 2023
Caution with AI-generated content in biomedicineAlex Zhavoronkov
Journal of Chemical Information and Modeling|May 30, 2020
Medicinal Chemists versus Machines Challenge: What Will It Take to Adopt and Advance Artificial Intelligence for Drug Discovery?Alex Zhavoronkov
Oncoscience|January 2, 2023
Rapamycin in the context of Pascal's Wager: generative pre-trained transformer perspective, Alex Zhavoronkov
Science (New York, N.Y.)|May 9, 2020
The inherent challenges of classifying senescenceAlex Zhavoronkov
Aging|April 2, 2020
Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infectionsAlex Zhavoronkov
Psychology Research and Behavior Management|February 6, 2015
Longevity expectations in the pension fund, insurance, and employee benefits industriesAlex Zhavoronkov
Molecular Pharmaceutics|October 2, 2018
Artificial Intelligence for Drug Discovery, Biomarker Development, and Generation of Novel ChemistryAlex Zhavoronkov
Trends in Molecular Medicine|August 11, 2019
The Advent of Human Life Data Economics: (Trends in Molecular Medicine 25, 566-570; 2019)Alex Zhavoronkov, George Church
International Journal of Environmental Research and Public Health|November 13, 2013
Biomedical progress rates as new parameters for models of economic growth in developed countriesAlex Zhavoronkov, Maria Litovchenko
Clinical Pharmacology and Therapeutics|December 26, 2024
Progress, Pitfalls, and Impact of AI-Driven Clinical TrialsDominika Wilczok, Alex Zhavoronkov
Pageof 24